期刊
JOURNAL OF CLINICAL MICROBIOLOGY
卷 49, 期 11, 页码 3931-3933出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01176-11
关键词
-
类别
资金
- Ortho-McNeil Johnson Johnson Co.
- Merck Co., Inc.
- Pfizer, Inc.
Using the updated 2010 CLSI carbapenem breakpoints for the Enterobacteriaceae, nonsusceptibility to ertapenem and imipenem predicted the presence of bla(KPC) poorly, especially among Escherichia coli and Enterobacter species. In regions where KPC-producing bacteria are endemic, testing for nonsusceptibility to meropenem may provide improved accuracy in identifying these isolates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据